Singapore-based marine alternatives biotechnology company UMAMI Bioworks has announced a new cell-cultivated supplement line it has dubbed Marine Radiance, which it said will give consumers access to omega fatty acids, collagen, and marine bioactive peptides without taxing wild fish populations.
The company, which has expanded its cell-cultivated initiatives into pet food and skin care – while also partnering with research institutions to increase the sustainability of cell-culturation and conduct other research – has repeatedly said that relieving the strain on the world’s oceans is one of its primary goals.
“[UMAMI’s] mission [is] to provide high-quality, sustainable protein sources while alleviating the ecological pressure on our oceans,” CEO and founder Mihir Pershad said in 2024, regarding a collaboration to produce marine cell-cultivated pet food without traditional fish.
In a release about the new supplement line, UMAMI said that the choice to move into cell-cultivated supplements was driven by consumer trends and a similar need for protecting oceans.
“The demand for marine-derived nutrition is rising exponentially, yet current supply chains cannot meet this need without compromising ocean health,” said Product Manager Mehaa Bajaj.
UMAMI Bioworks pointed to potential strain on ocean resources for products like krill oil. The krill fishery near Antarctica was shut down early in 2025 for the first time ever due to high volumes of catch – though fishing companies said it is not a sustainability issue.
“More vegetarians and flexitarians [are] seeking essential amino acids, aging populations [are] turning to collagen and metabolic support, and wellness buyers [are] demanding sustainable alternatives to categories like krill oil that face ecological and supply constraints,” the company said. “The world is hungry for marine derived nutrition.”
UMAMI’s technology, which can produce cell cultivated alternatives from eel, salmon, and tuna cell-lines, “positions the company to address the rapidly expanding USD 704 billion [EUR 601 billion] global supplement market while solving supply bottlenecks and sustainability risks of conventional marine sources.”
UMAMI’s products, the company said, also have the added benefit of being traceable, and reliably free of heavy metals or microplastics.
The company’s biotechnology can “bring clean, scalable, and high-performance marine bioactives to market,” said Bajaj.
The first supplements in the new line will include omega fatty acids and peptides which aid the efficacy of GLP-1 drugs. A marine nutrition complex, which will deliver the “nutrition density of fish,” is currently under production.
The supplements will be brought to market, UMAMI said, through partnerships with global wellness brands, the names of which it did not announce.
